Orthopediatrics Corp cash flow statement
In fiscal 2025, Orthopediatrics Corp's operations generated −$4.9m of cash; it spent $11.1m on capital projects, leaving free cash flow of −$16.0m.
Cash flow statement
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −1 | −1 | −7 | −16 | −18 | −19 | −13 | −22 | −27 | −27 | −5 | 12 |
| Depreciation and amortisation | 2 | 2 | 2 | 3 | 5 | 8 | 11 | 13 | 17 | 19 | 21 | 23 |
| Stock-based pay | 1 | 1 | 3 | 3 | 3 | 6 | 6 | 7 | 11 | 14 | 18 | 17 |
| Capital spending | 2 | 4 | 5 | 5 | 12 | 11 | 8 | 10 | 17 | 14 | 11 | 9 |
| Free cash flow | −3 | −5 | −12 | −21 | −30 | −29 | −21 | −32 | −44 | −41 | −16 | 3 |
| Free cash flow after stock pay | −4 | −7 | −16 | −24 | −32 | −35 | −27 | −38 | −54 | −55 | −34 | −14 |
| Dividends paid | 0 | 0 | 6 | 0 | 0 | — | — | — | — | — | — | — |
| Shares issued | 0 | 0 | 54 | 43 | 60 | 70 | 0 | 139 | 0 | 0 | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −4 | −4 | −10 | −1 | 10 | −3 | 1 | 5 |
| Depreciation and amortisation | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 6 |
| Stock-based pay | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 4 |
| Capital spending | −0 | 4 | 3 | 3 | 1 | 2 | 4 | 3 |
| Free cash flow | −4 | −8 | −14 | −3 | 10 | −5 | −3 | 2 |
| Free cash flow after stock pay | −8 | −12 | −19 | −8 | 5 | −9 | −7 | −3 |
Compare with peers
- Lemaitre Vascular Inc cash flow
- Axogen, Inc. cash flow
- Cerus Corp cash flow
- Establishment Labs Holdings Inc. cash flow
- Skinhealth Systems Inc. cash flow
Head to head: KIDS vs LMATAXGN vs KIDSCERS vs KIDSESTA vs KIDS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies